Table 4. Difference in BP in patients with ESA according to dose.
| ESA (units/week) | Unadjusted | Adjusted1 | Adjusted2 | ||||
| SBP (mmHg) | 10–2000 | ref | ref | ref | |||
| 2001–4000 | 1.0 | (−3.3;5.3) | 1.2 | (−3.1;5.4) | 0.7 | (−3.6;4.8) | |
| 4001–6000 | 1.3 | (−4.2;6.8) | 1.7 | (−3.8;7.1) | 1.2 | (−4.3;6.6) | |
| >6000 | 5.2 | (−0.1;10.4) | 5.0 | (−0.2;10.2) | 3.7 | (−1.6;9.0) | |
| DBP (mmHg) | 10–2000 | ref | ref | ref | |||
| 2001–4000 | 0.1 | (−2.1;2.3) | 0.0 | (−2.2;2.2) | 0.2 | (−2.0;2.4) | |
| 4001–6000 | 0.5 | (−2.4;3.3) | 0.4 | (−2.4;3.3) | 0.7 | (−2.1;3.6) | |
| >6000 | 0.5 | (−2.3;3.2) | 0.5 | (−2.2;3.3) | 1.1 | (−1.7;3.8) | |
Values are presented as mean difference in blood pressure (with 95% Confidence Interval).
1 Adjusted for age and sex.
2 Adjusted for age, sex, BMI, Diabetes Mellitus, Cardiovascular disease, eGFR.
Abbreviations: ESA = Erythropoiesis-Stimulating Agent, SBP = Systolic Blood Pressure, DBP = Diastolic Blood pressure, ref = Reference, BMI = Body Mass Index, eGFR = estimated Glomerular Filtration Rate.